At Least 10 European Countries Suspended Use Of Oxford - Astrazeneca Covid-19 Vaccine As Serious Side Effects Found .

 

Many European countries have temporarily suspended use of AstraZeneca vaccines after blood clots in some people who had been inoculated.

With at least 10 countries suspending the use of the Covid-19 vaccine by Astra- Zeneca-Oxford University amid concerns that it may be potentially causing dangerous blood clots in some recipients, India, too, has decided to review the hospitalisations and deaths in people who took Covishield,

Covishield is developed by AstraZeneca and Oxford University and produced by Pune-based Serum Institute of India. Bharat Biotech has developed Covaxin in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

 Countries like Austria, Norway , Estonia, Latvia, Lithuania and Luxemburg have withdrawn the use of one batch of Astrazeneca vaccine, while others including Denmark have suspended the use of all its supply for two weeks, pending investigations. As per reports, at least 22 recipients of AstraZeneca had developed coagulation disorder and pulmonary embolism in various European countries. 

However, the World Health Organization on Friday said there was no reason to stop using AstraZeneca’s vaccine. Its vaccines advisory committee was looking at safety data and WHO stressed that no link had been established between the vaccine and clotting. Senior authorities in the Union health ministry and national committee on Adverse Event Following Immunisation said the development is assessed in India’s context.